Who are Assembly Biosciences, Inc.'s main suppliers?

Assembly Biosciences, Inc. (ASMB) key suppliers include: GUGGENHEIM-SECURITIES-LLC, UBS-SECURITIES-LLC, Gilead Sciences, Inc., MMTec, Inc.. View the full supplier network at chainsifter.com/chain/ASMB.

Who are Assembly Biosciences, Inc.'s major customers?

Assembly Biosciences, Inc. (ASMB) key customers include: Gilead Sciences, Inc., Gilead Sciences, Inc., DELAWARE-GENERAL-CORPORATION. View the full customer network at chainsifter.com/chain/ASMB.

What sector is Assembly Biosciences, Inc. in?

Assembly Biosciences, Inc. (ASMB) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

Assembly Biosciences, Inc. Suppliers, Customers & Supply Chain (ASMB)

4Suppliers

3Customers

3Debt Items

20Related Chains

Source-Backed Evidence Depth

Assembly Biosciences, Inc. (ASMB) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

11Total relationships

3Distinct source URLs

6High confidence

0.804Average confidence

2026-10-28Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Assembly Biosciences, Inc. Suppliers

Ticker	Name	Confidence	Evidence
GUGGENHEIM-SECURITIES-LLC	GUGGENHEIM-SECURITIES-LLC	92%	On May 21, 2026, Assembly Biosciences, Inc. (the "Company") entered into an underwriting agreement (the "Underwriting Agreement") with Guggenheim Securities, LLC ("Guggenheim Securities") and UBS Sec…
UBS-SECURITIES-LLC	UBS-SECURITIES-LLC	92%	On May 21, 2026, Assembly Biosciences, Inc. (the "Company") entered into an underwriting agreement (the "Underwriting Agreement") with Guggenheim Securities, LLC ("Guggenheim Securities") and UBS Sec…
GILD	Gilead Sciences, Inc.	72%	Reciprocal relationship from GILD graph: 48 434 238 116 47 401 8 % Total HIV 15,918 2,339 1,355 19,612 14,848 2,102 1,226 18,175 8 % Liver Disease Sofosbuvir/Velpatasvir (3) 922 299 374 1,596 859 323…
MTC	MMTec, Inc.	62%	Reciprocal relationship from MTC graph: Reciprocal relationship from ASMB graph: Reciprocal relationship from MTC graph: Reciprocal relationship from ASMB graph: Reciprocal relationship from MTC grap…

Assembly Biosciences, Inc. Customers

Ticker	Name	Confidence	Evidence
GILD	Gilead Sciences, Inc.	72%	Reciprocal relationship from GILD graph: Reciprocal relationship from ASMB graph: Reciprocal relationship from GILD graph: Reciprocal relationship from ASMB graph: Reciprocal relationship from GILD g…
GILD	Gilead Sciences, Inc.	72%	nd ABI-1179 (1179); (2) an orally bioavailable hepatitis delta virus (HDV) entry inhibitor, ABI-6250 (6250); and (3) a highly potent next-generation capsid assembly modulator (CAM) designed to disrup…
DELAWARE-GENERAL-CORPORATION	DELAWARE-GENERAL-CORPORATION	62%	manufacturers with whom we contract could be foreign, which increases the risk of shipping delays and adds the risk of import restrictions. • We do not have complete control over, and cannot ensure, …

Assembly Biosciences, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
ASMB-DEBT-7881	Warrants outstanding: 1040820	90%	xbrl warrant detail from xbrl 2025-12-31.
ASMB-DEBT	Debt stack $419,380	90%	Market cache reports total debt of $419,380.
ASMB-DEBT-7882	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2013-12-31.

Assembly Biosciences, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Assembly Biosciences, Inc..

Assembly Biosciences, Inc. Ownership

Holder	Name	Confidence	Evidence
ASMB-OWNER-GILEAD-SCIENCES-INC	GILEAD SCIENCES, INC.	90%	13F overlay lists GILEAD SCIENCES, INC. as top holder; 75 tracked holders.

Assembly Biosciences, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
PYXS	Pyxis Oncology, Inc.	100.00	2
MCK	McKesson Corporation	100.00	2
TNGX	Tango Therapeutics, Inc.	100.00	2
MTC	MMTec, Inc.	100.00	1	['supplier']
KYMR	Kymera Therapeutics, Inc.	100.00	2
KYTX	Kyverna Therapeutics, Inc.	100.00	2
CHRS	Coherus Oncology, Inc.	100.00	2
MGNX	MacroGenics, Inc.	100.00	2
AVIR	Atea Pharmaceuticals, Inc.	100.00	2
CRIS	Curis, Inc.	100.00	2
RCUS	Arcus Biosciences, Inc.	100.00	2
GLMD	Galmed Pharmaceuticals Ltd.	100.00	2
CABA	Cabaletta Bio, Inc.	100.00	2
GDTC	CytoMed Therapeutics Limited	100.00	2
GILD	Gilead Sciences, Inc.	100.00	1	['customer', 'supplier']
SDGR	Schrödinger, Inc.	100.00	2
IBIO	iBio, Inc.	100.00	2
CAH	Cardinal Health, Inc.	100.00	2
NRIX	Nurix Therapeutics, Inc.	100.00	2
VEEV	Veeva Systems Inc.	100.00	2

Assembly Biosciences, Inc. Supply Chain